PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
All Communities

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Stalevo, Stalevo 100, Stalevo 150, Stalevo 200, Stalevo 50

What is Carbidopa-Entacapone-Levodopa? The combination of levodopa, carbidopa, and entacapone is used for Parkinson's Disease. Levodopa is the precursor to dopamine, carbidopa slows the breakdown of levodopa, while entacapone improves the efficacy of levodopa.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

240 patients in the community are taking or have taken Carbidopa-Entacapone-Levodopa.

Reason # Patients Percentage of patients
Treat Parkinson's 172 71%
Other 12 5%
Stiffness/spasticity 11 4%
Slowness 2 <1%
Support another treatment 2 <1%
Mobility 2 <1%
disease-related symptoms 2 <1%
Stiffness 1 <1%
Memory problems 1 <1%
Don't know 1 <1%
Brain fog 1 <1%
General health 1 <1%
Treat my PSP 1 <1%
Slurred speech 1 <1%
Tremors, hands 1 <1%

Dosages

Based on the patients currently taking Carbidopa-Entacapone-Levodopa.

Top 10 (Show all)

All (Show Top 10)

  0 mg Daily 100 mg As needed 200 mg All the time (24/7) 325 mg All the time (24/7) 0.05 mg Daily 3 mg Daily 3 other Daily 4 mg Daily 4 other Daily 6 mg Daily 6 other Daily 25 mg Daily 37.5 mg Daily 50 mg Daily 80 mg Daily 100 mg Daily 125 mg Daily 150 mg Daily 200 mg Daily 200 other Daily 250 mg Daily 300 mg Daily 350 mg Daily 400 mg Daily 450 mg Daily 500 mg Daily 600 mg Daily 700 mg Daily 750 mg Daily 800 mg Daily 850 mg Daily 900 mg Daily 1000 mg Daily 1200 mg Daily 1400 mg Daily 1600 mg Daily
  16 Number of Patients: 16 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 7 Number of Patients: 7 18 Number of Patients: 18 2 Number of Patients: 2 2 Number of Patients: 2 23 Number of Patients: 23 1 Number of Patients: 1 19 Number of Patients: 19 6 Number of Patients: 6 7 Number of Patients: 7 29 Number of Patients: 29 2 Number of Patients: 2 3 Number of Patients: 3 13 Number of Patients: 13 1 Number of Patients: 1 3 Number of Patients: 3 9 Number of Patients: 9 4 Number of Patients: 4 3 Number of Patients: 3 1 Number of Patients: 1  

Duration

How long current patients have been taking Carbidopa-Entacapone-Levodopa or how long patients were taking Carbidopa-Entacapone-Levodopa before stopping.

Currently taking Carbidopa-Entacapone-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
15
16
21
22
53

Stopped taking Carbidopa-Entacapone-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
8
6
12
4
7
Why Patients Stopped Taking Carbidopa-Entacapone-Levodopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 19 48% Side effects too severe: 48%
Doctor's advice 8 20% Doctor's advice: 20%
Did not seem to work 7 18% Did not seem to work: 18%
Expense 6 15% Expense: 15%
Other 5 13% Other: 13%
Not indicated 4 10% Not indicated: 10%
Personal research 1 3% Personal research: 3%

Patient Reported Evaluations

Results from 27 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 63% 15
Moderate 29% 7
Can't tell 8% 2

Treat Parkinson's

Side-effects (as an overall problem)

Severe 4% 1
Moderate 22% 6
Mild 37% 10
None 37% 10

Top reported side-effects include: legs cramping when wearing off, Slight nausea, Increased dyskenisia

Summary results are based on 27 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 27)

  • TomBerdine
    Sex: M
    Mouth/throat: moderate
    Arms: moderate
    Chest: none
    Legs: mild
    See profile
  • TomBerdine
  • by TomBerdine
    Aug 20, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
Longer lasting then the PARCOPA but much slower to take effect. About 45minutres to an hour. But last up to 3hours where the PARCOPA lasts only an hour or a little more.

  • ProfGumbySan
    Sex: M
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: none
    See profile
  • ProfGumbySan
  • by ProfGumbySan
    Aug 27, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Treat Parkinson's
Advice/Tips
Re: side effects, none I'm aware of.

See all evaluation results for Carbidopa-Entacapone-Levodopa



Back to top